Christine Lennon

General Manager

Incyte Biosciences Canada

In April 2020, Christine became the first General Manager and employee for Incyte Biosciences Canada.
Prior to Incyte, Christine was CEO of Epigene Therapeutics, a spinout of Neomed, now Admare Bioinnovations. Prior to that, she spent eight years with Novartis as Canadian Commercial Head, Solid Tumors/Rare Disorders; General Manager – Oncology, Novartis Ireland; Head of Policy, Market Access, Stakeholder Relations, Novartis Oncology Canada. Christine also held leadership roles with Neurochem, Shire (now Takeda), BioChem Pharma and with the National Research Council of Canada (NRC) Industrial Research Assistance Program. Christine has been an advisor to life sciences startups and an executive-in-residence and advisor to healthcare venture capital teams at Business Development Bank of Canada (now Amplitude Ventures) and at Caisse de Dépôt et Placement du Québec.

Christine holds an MBA and BSc from McGill University and her Institute of Corporate Directors designation (ICD.D) from Rotman School of Management, University of Toronto. Christine serves as a judge and mentor for McGill’s Dobson Centre for Entrepreneurship and McGill’s Desautels MBA School. Christine is a McGill Scarlet Key Award Recipient and was named a Healthcare Businesswomen Association Luminary in 2022. Christine is a Board member of Montréal inVivo, Innovative Medicines Canada and Research Canada.

All Sessions by Christine Lennon

Printer Friendly Download 2024 Agenda

Agenda: Day 1 Oct 29, 2024

Agenda: Day 2 Oct 30, 2024